BACKGROUND & AIMS: Chronic hepatitis B (CHB) remains a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, yet treatment uptake is…
INTRODUCTION: Glecaprevir/pibrentasvir (G/P) is globally approved for the treatment of chronic hepatitis C virus (HCV) infection and for acute HCV infection in the…
BACKGROUND: People who experience criminalization, such as those who use drugs, are incarcerated, and are affected by homelessness, have a high prevalence…